News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Giuffre Randall Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/03/2023 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 35,130 shares
@ $1.53, valued at
$53.7k
|
|
| 12/12/2022 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Bought 20,000 shares
@ $1.4, valued at
$28k
Bought 37,079 shares
@ $1.43, valued at
$53k
|
|
| 12/08/2022 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Bought 2,300 shares
@ $1.35, valued at
$3.1k
Bought 22,574 shares
@ $1.4, valued at
$31.6k
|
|
| 12/05/2022 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Bought 819 shares
@ $1.19, valued at
$974.6 |
|
| 12/01/2022 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Bought 18,125 shares
@ $1.19, valued at
$21.6k
Bought 2,970 shares
@ $1.19, valued at
$3.5k
Bought 46,133 shares
@ $1.2, valued at
$55.4k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 15,026 shares
@ $3.58, valued at
$53.8k
|
|
| 07/16/2021 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 9,393 options to buy
@ $3.64, valued at
$34.2k
|
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2020 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Bought 15,000 shares
@ $4.2608, valued at
$63.9k
|
|
| 06/02/2020 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 7,784 shares
@ $4.59, valued at
$35.7k
Granted 13,306 options to buy
@ $4.64, valued at
$61.7k
|
|
| 06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2018 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Bought 11,250 shares
@ $4, valued at
$45k
|
|
| 12/06/2018 |
3
| Giuffre Randall Michael (Director) has filed a Form 3 on DiaMedica Therapeutics Inc. |
|
|